Unknown

Dataset Information

0

MiR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma.


ABSTRACT: Background:Many studies have used miRNA to modulate osteosarcoma development by regulating protein expression, and these studies showed that the expression of EGFR is increased in osteosarcoma. Methods:Western blot, real-time PCR and immunohistochemical were used to detect the expression of EGFR and miR-141 in osteosarcoma tissues and cells. The correlation between miR-141 and the grading of osteosarcoma and the correlation with the survival time of the patients were analyzed. After predicting the target effect of miR-141 on EGFR by miRDB, correlation analysis was used to analyze the correlation between miR-141 and EGFR. Luciferase reporter gene, western blot and real-time PCR were used to detect the targeting effect of miR-141 on EGFR. Then we detected the effect of miR-141 on proliferation by MTT and PI staining. The effect of miR-141 on cell apoptosis was detected by Hochest33258 and AV-PI staining, and the effect of miR-141 on cell migration was detected by Transwell. The regulatory effects of miR-141 on related proteins were detected by western blot and real-time PCR. Finally, we transfected EGFR and EGFR DEL (mutation with miR-141 binding site) in osteosarcoma cells, and detected the effects of miR-141 on cell proliferation, apoptosis, migration and related proteins. Results:The expression of miR-141-3p was negatively correlated with the expression of EGFR in osteosarcoma. The overexpression of miR-141-3p was not only closely related to the classification and size of the osteosarcoma but also had a negative effect on the growth and migration of the osteosarcoma through negative regulation of the expression of EGFR. MiR-141 can inhibit the growth and metastasis of osteosarcoma cells by targeting EGFR and affecting its downstream pathway proteins. Conclusion:Our study provides miR-141-3p may be a new theoretical basis for the treatment of osteosarcoma.

SUBMITTER: Wang J 

PROVIDER: S-EPMC6074763 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma.

Wang Jiashi J   Wang Guangbin G   Li Bin B   Qiu Chuang C   He Ming M  

OncoTargets and therapy 20180731


<h4>Background</h4>Many studies have used miRNA to modulate osteosarcoma development by regulating protein expression, and these studies showed that the expression of EGFR is increased in osteosarcoma.<h4>Methods</h4>Western blot, real-time PCR and immunohistochemical were used to detect the expression of EGFR and miR-141 in osteosarcoma tissues and cells. The correlation between miR-141 and the grading of osteosarcoma and the correlation with the survival time of the patients were analyzed. Aft  ...[more]

Similar Datasets

| S-EPMC10506581 | biostudies-literature
| S-EPMC8878724 | biostudies-literature
| S-EPMC7286874 | biostudies-literature
| S-EPMC5085220 | biostudies-literature
| S-EPMC8471791 | biostudies-literature
| S-EPMC6019570 | biostudies-literature
| S-EPMC8917307 | biostudies-literature
| S-EPMC5602517 | biostudies-literature
| S-EPMC9361323 | biostudies-literature
| S-EPMC6542769 | biostudies-literature